SYRA HEALTH CORP. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SYRA HEALTH CORP. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $14.80K, a 98.26% decline year-over-year.
- SYRA HEALTH CORP. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $850.13K.
- SYRA HEALTH CORP. stock issued during period, value, new issues for the quarter ending 2022-12-31 was $0.00.
- SYRA HEALTH CORP. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $514.92K.
- SYRA HEALTH CORP. stock issued during period, value, new issues for fiscal 2023 was $4.74M, a 103.93% increase from fiscal 2022.
- SYRA HEALTH CORP. stock issued during period, value, new issues for fiscal 2022 was $2.32M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $14.80K S-1 · filed 2026-09-14 | |
| 2025-03-31 | $14.80K S-1 · filed 2026-09-14 | |
| 2024-12-31 | $850.13K S-1 · filed 2026-09-14 | |
| 2024-03-31 | $850.13K 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $4.74M 10-K · filed 2024-03-25 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $2.32M 10-K · filed 2024-03-25 |
| 2022-09-30 | $514.92K 10-Q · filed 2023-11-14 |